Varying practices in tumor regression grading of gastrointestinal carcinomas after neoadjuvant therapy: results of an international survey
Sign Up to like & getrecommendations! Published in 2019 at "Modern Pathology"
DOI: 10.1038/s41379-019-0393-7
Abstract: Tumor regression grading is routinely performed on neoadjuvantly treated gastrointestinal cancer resections. Challenges in tumor regression grading include grossing standards, multiple grading systems, and difficulty interpreting therapy-induced changes. We surveyed gastrointestinal pathologists around the world… read more here.
Keywords: regression; percent; therapy; regression grading ... See more keywords
Pancreatic ductal adenocarcinoma: tumour regression grading following neoadjuvant FOLFIRINOX and radiation
Sign Up to like & getrecommendations! Published in 2020 at "Histopathology"
DOI: 10.1111/his.14086
Abstract: In the adjuvant setting, when compared to gemcitabine, patients with pancreatic ductal adenocarcinoma (PDAC) treated with FOLFIRINOX (Folinic Acid, Fluorouracil, Irinotecan, and Oxaliplatin) show superior survival. In this study, we quantitatively assess the pathological tumour… read more here.
Keywords: tumour regression; regression grading; pancreatic ductal; ductal adenocarcinoma ... See more keywords
ASO Author Reflections: Prognostic Index after Neoadjuvant Chemotherapy (PINC) in Pancreatic Ductal Adenocarcinoma as Novel Tumor Regression Grading System
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Surgical Oncology"
DOI: 10.1245/s10434-022-11461-z
Abstract: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies. Although surgery is the mainstay of therapy, up to 80% of patients relapse after curative resection, suggesting the presence of systemic diffusion in the… read more here.
Keywords: pancreatic ductal; neoadjuvant chemotherapy; chemotherapy; tumor regression ... See more keywords
Prognostic Value of Tumor Regression Grading in Patients Treated With Neoadjuvant Chemotherapy Plus Surgery for Gastric Cancer
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.587856
Abstract: Objective To validate the prognostic value of tumor regression grading (TRG) and to explore the associated factors of TRG for advanced gastric cancer (AGC) with neoadjuvant chemotherapy (NACT) plus surgery. Methods Two hundred forty-nine AGC… read more here.
Keywords: regression grading; neoadjuvant chemotherapy; regression; tumor regression ... See more keywords